← Back
$HALO All transactions

HALOZYME THERAPEUTICS, INC.

▼ SELL 10b5-1 Plan

$ Value

$38K

Shares

500

Price

$76

Filed

Oct 1

Insider

Name

Connaughton Bernadette

Title

CIK

0001662521

Roles

Director

Transaction Details

Transaction Date

2025-10-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

44,952

Footnotes

The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $74.64 to $75.55. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $75.64 to $75.92. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Filing Info

Accession No.

0001662521-25-000005

Form Type

4

Issuer CIK

0001159036

Connaughton Bernadette's History

Date Ticker Type Value
2026-01-05 HALO $140K
2025-12-01 HALO $59K
2025-11-10 HALO $137K
2025-10-01 HALO $113K
2025-10-01 HALO $38K
2025-09-02 HALO $7K
2025-09-02 HALO $219K
2025-09-02 HALO $68K
2025-06-06 EDIT A $0
2025-05-01 HALO A $0

Other Insiders at HALO (90d)

Insider Bought Sold Last
RAMSAY DAVID A
Interim CFO
2026-04-01
Torley Helen
PRESIDENT AND CEO
$3.2M 2026-04-06